BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.187
+0.019 (11.32%)
Mar 9, 2026, 3:12 PM EDT - Market open
BioAtla Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 14 | 34 | 118 | 391 | 723 | 1,145 | |
| Market Cap Growth | -46.71% | -70.91% | -69.81% | -45.97% | -36.84% | - | |
| Enterprise Value | 10 | -21 | -21 | 217 | 453 | 1,188 | |
| Last Close Price | 0.17 | 0.59 | 2.46 | 8.25 | 19.63 | 34.01 | |
| PS Ratio | - | 3.12 | - | - | 2892.35 | 2668.76 | |
| PB Ratio | - | 2.40 | 1.67 | 2.17 | 3.43 | 5.45 | |
| P/TBV Ratio | - | 2.40 | 1.67 | 2.17 | 3.43 | 5.45 | |
| EV/Sales Ratio | - | - | - | - | 1812.65 | 2768.30 | |
| Debt / Equity Ratio | -0.20 | 0.06 | 0.04 | 0.02 | 0.03 | 0.00 | |
| Net Debt / Equity Ratio | 0.07 | -3.38 | -1.54 | -1.17 | -1.14 | -1.13 | |
| Net Debt / EBITDA Ratio | 0.03 | 0.66 | 0.85 | 1.98 | 2.52 | 8.18 | |
| Net Debt / FCF Ratio | 0.04 | 0.67 | 1.05 | 2.33 | 3.80 | 6.44 | |
| Asset Turnover | - | 0.13 | - | - | 0.00 | 0.00 | |
| Quick Ratio | 0.46 | 3.37 | 3.93 | 9.32 | 12.37 | 7.40 | |
| Current Ratio | 0.54 | 3.52 | 4.11 | 9.53 | 12.48 | 7.46 | |
| Return on Equity (ROE) | - | -164.30% | -98.37% | -54.44% | -45.34% | -46.57% | |
| Return on Assets (ROA) | -105.09% | -53.71% | -46.93% | -28.15% | -24.14% | -14.80% | |
| Return on Capital Employed (ROCE) | 3164.50% | -195.20% | -142.00% | -53.40% | -41.10% | -14.20% | |
| Earnings Yield | -519.26% | -203.40% | -104.70% | -27.26% | -13.19% | -3.13% | |
| FCF Yield | -457.99% | -209.70% | -88.29% | -23.21% | -8.73% | -3.23% | |
| Buyback Yield / Dilution | -16.89% | -1.67% | -22.73% | -12.63% | -310.07% | 84.56% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.